Webcast résultats semestriels 2023

Webcast résultats annuels 2022

Webcast partenariat Donesta

Pharmaceuticals in the Environment: Current challenges and tomorrow’s solutions to protect wildlife

Efficacy and Safety of Estetrol (E4), a Promising New Treatment for Menopausal Vasomotor Symptoms: Results of a randomized, double- blind, placebo-controlled Phase 3 trial (North American Menopause Society 2022 meeting 12-15 Oct, Atlanta, GA)

Estetrol (E4), a landmark in the making? Before and beyond reproductive age: new therapeutic opportunities for E4 ⁠- Report on Scientific Symposium (20th ISGE World Congress)

Webcast résultats annuels 2021

Premiers résultats positifs pour Donesta® Phase 3

2021 Investor Day Webcast

2021 Half Year Results Webcast